These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35347801)

  • 21. Clinical outcome in dogs with nasal tumors treated with intensity-modulated radiation therapy.
    Hunley DW; Mauldin GN; Shiomitsu K; Mauldin GE
    Can Vet J; 2010 Mar; 51(3):293-300. PubMed ID: 20514254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
    Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
    Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 × 10 Gy) (2010-2015).
    Yoshikawa H; Lafferty MH; Griffin LR; LaRue SM
    J Vet Intern Med; 2023; 37(6):2356-2367. PubMed ID: 37688322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiation therapy for the treatment of macroscopic canine anal gland tumors - a retrospective study].
    Rohrer Bley C; Czichon F; Körner M; Staudinger C; Meier VS
    Schweiz Arch Tierheilkd; 2022 Nov; 164(11):789-799. PubMed ID: 36325642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion.
    Zhang Z; Jiang L; Bi R; Wu X; Zhu J; Ke G
    Oncologist; 2022 Feb; 27(1):e53-e63. PubMed ID: 35305100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study.
    Lan W; Lihong L; Chun H; Shutang L; Qi W; Liang X; Xiaoning L; Likun L
    Strahlenther Onkol; 2022 Sep; 198(9):802-811. PubMed ID: 35029718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Description and efficacy of a response-based "QUAD" cyclical hypofractionated palliative-intent radiation protocol in dogs with macroscopic solid tumours: 108 cases.
    Sylvester SR; Henry JG; Basran PS; McEntee MC
    Vet Comp Oncol; 2023 Sep; 21(3):378-390. PubMed ID: 37068761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
    Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis.
    Sun H; Liu C; Zhang J; Yang G; Han D; Liu T; Huang W; Li B
    Radiother Oncol; 2022 Jul; 172():140-146. PubMed ID: 35101460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HYPOFRACTIONATED RADIOTHERAPY FOR MACROSCOPIC CANINE SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY OF 50 CASES TREATED WITH A 5 × 6 GY PROTOCOL WITH OR WITHOUT METRONOMIC CHEMOTHERAPY.
    Cancedda S; Marconato L; Meier V; Laganga P; Roos M; Leone VF; Rossi F; Bley CR
    Vet Radiol Ultrasound; 2016 Jan; 57(1):75-83. PubMed ID: 26551348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
    Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
    BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors.
    Adams WM; Miller PE; Vail DM; Forrest LJ; MacEwen EG
    Vet Radiol Ultrasound; 1998; 39(5):475-81. PubMed ID: 9771602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose hypofractionated frameless volumetric modulated arc radiotherapy is a feasible method for treating canine trigeminal nerve sheath tumors.
    Dolera M; Malfassi L; Marcarini S; Mazza G; Carrara N; Pavesi S; Sala M; Finesso S; Urso G
    Vet Radiol Ultrasound; 2018 Sep; 59(5):624-631. PubMed ID: 29885013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: A modified Phase I clinical trial.
    Ge X; Xue X; Liu H; Wang Y; Xiao Z; Tian L; Chang X; Lin Q; Yu J
    J Cancer Res Ther; 2018; 14(7):1482-1491. PubMed ID: 30589027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
    Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
    Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of local residual disease and local failure after intensity modulated/image guided radiation therapy for sinonasal tumors in dogs.
    Poirier VJ; Koh ESY; Darko J; Fleck A; Pinard C; Vail DM
    J Vet Intern Med; 2021 Mar; 35(2):1062-1072. PubMed ID: 33660342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
    Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
    Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short survival time following palliative-intent hypofractionated radiotherapy for non-resectable canine thyroid carcinoma: A retrospective analysis of 20 dogs.
    Tsimbas K; Turek M; Christensen N; Vail DM; Forrest L
    Vet Radiol Ultrasound; 2019 Jan; 60(1):93-99. PubMed ID: 30180282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.